HALOZYME THERAPEUTICS INC·4

Feb 5, 8:20 PM ET

Shepard H. Michael 4

4 · HALOZYME THERAPEUTICS INC · Filed Feb 5, 2013

Insider Transaction Report

Form 4
Period: 2013-02-02
Shepard H. Michael
See General Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2013-02-02+8,29019,690 total
  • Exercise/Conversion

    Common Stock

    2013-02-02+3,50823,198 total
Footnotes (2)
  • [F1]Represents net settlement for the vesting of 13,888 shares of a restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 8,290 shares of Halozyme common stock. 5,598 shares were withheld as payment for minimum statutory tax withholding requirements.
  • [F2]Represents net settlement for the vesting of 6,250 shares of another restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 3,508 shares of Halozyme common stock. 2,742 shares were withheld as payment for minimum statutory tax withholding requirements.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT